Skip to main content
. 2023 Mar 20;13(2):454–469. doi: 10.3390/clinpract13020041

Figure 2.

Figure 2

Figure 2

Effects on glucometabolism; (A) HOMA-IR (homeostatic model assessment for insulin resistance) [5,8,13,14,15,17,18,22,23]; (B) FSG (fasting serum glucose) [5,8,12,13,14,15,16,17,18,19,20,22,23,24]; (C) FSI (fasting serum insulin) [8,13,14,16,17,18,19,23]; (D) HBA1c (glycated hemoglobin) [5,8,12,13,14,15,17,18,20,21,22,23,24]; WMD—weighted mean difference; CI—confidence interval.